RightFit
Not yet recruitingPhase not listed

Blood Pressure Goal in Preterm Preeclampsia

Blood Pressure Goal in Preterm Preeclampsia (BLiPP)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients with hypertensive disorders of pregnancy (HDP) with severe features \< 34 weeks gestational age (GA), undergoing expectant management between tight and permissive blood pressure (BP) groups.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria * Pregnant individuals * Age ≥ 18 years old * HDP with severe features * Planned inpatient admission for expectant management until delivery * GA 24 - ≤ 32 weeks GA * Singleton, non-anomalous fetus * Anticipated delivery at the study institution Exclusion criteria: * HDP with severe features \> 32 weeks gestation at the time of admission * Poorly controlled preexisting chronic hypertension on ≥2 oral antihypertensive medications * Preexisting CKD with serum creatinine \> 1.0 * Contraindications to expectant management of preeclampsia with severe features per ACOG (attached) * Severe FGR (EFW \< 3rd percentile) or FGR with umbilical artery doppler abnormalities (absent or reversed end diastolic flow) at the time of enrollment * Multiple gestation * Major fetal anomaly (attached) * PPROM/active preterm labor

Study sites (1)

OH